Skip to content

Coagulation Factor VIII

Published: July 26, 2026Updated: July 26, 2026

Novoeight is a recombinant antihemophilic factor (recombinant factor VIII) used to treat and prevent bleeding in patients with hemophilia A. As a replacement therapy, it provides the clotting factor that is deficient in these patients, helping the blood clot normally. It is used for on-demand treatment of bleeding episodes, prevention of bleeding during surgery, and routine prophylaxis to reduce bleeding frequency.

Quick summary

Novoeight is a recombinant factor VIII replacement therapy used to treat and prevent bleeding in patients with hemophilia A.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy

Key facts at a glance

RxNorm
1607560
Generic
Novoeight
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Treatment and prevention of bleeding in patients with hemophilia A, including on-demand treatment of acute bleeding episodes, prevention of bleeding during surgical procedures, and routine prophylaxis to reduce the frequency of bleeding.

Novoeight is a recombinant clotting factor VIII that replaces the deficient or missing factor VIII in patients with hemophilia A. It works by temporarily correcting the coagulation defect in hemophilia A patients, enabling normal blood clotting.

Administered by intravenous injection. Patients or caregivers should be trained in proper administration techniques. Common side effects may include injection site reactions and development of factor VIII inhibitors. Monitor for signs of hypersensitivity reactions. This medication is contraindicated in patients with known hypersensitivity to any component of the product.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy